KLK3 and posterior cortical atrophy: Following radical prostatectomy, which is used as a therapeutic curative option for patients suffering from PCa, biochemical recurrence (BCR), defined as a re-increased serum concentration of prostate-specific antigen (PSA) of >0.2 μg/L [2,3], is clinically considered to be the first sign of disease recurrence [4,5].